The results showed that si-β-catenin or si-c-Myc significantly reduced the proliferative ability of HCC cells mediated by RGS19 overexpression, as determined by colony formation assays and CCK-8 assays (Fig. 5d–f). The gene discussed is MYC; the disease is hepatocellular carcinoma.